Expression of PKC-beta or cyclin D2 predicts for inferior survival in diffuse large B-cell lymphoma
Open Access
- 1 October 2005
- journal article
- research article
- Published by Elsevier BV in Laboratory Investigation
- Vol. 18 (10), 1377-1384
- https://doi.org/10.1038/modpathol.3800434
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Molecular Diagnosis of Primary Mediastinal B Cell Lymphoma Identifies a Clinically Favorable Subgroup of Diffuse Large B Cell Lymphoma Related to Hodgkin LymphomaThe Journal of Experimental Medicine, 2003
- Prognostic significance of bcl‐2, bax, and p53 expression in diffuse large B‐cell lymphomaAmerican Journal of Hematology, 2003
- Rituximab plus CHOP (R-CHOP) overcomes bcl-2--associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL)Blood, 2003
- PKC-β controls IκB kinase lipid raft recruitment and activation in response to BCR signalingNature Immunology, 2002
- CNOP for Diffuse Aggressive Non-Hodgkin's Lymphoma: The Nebraska Lymphoma Study Group ExperienceLeukemia & Lymphoma, 2002
- Diffuse large cell lymphomaCurrent Opinion in Oncology, 2001
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profilingNature, 2000
- Expression of classical protein kinase C subspecies in non‐neoplastic lymphocytes and non‐Hodgkin's lymphomas: An immunohistochemical studyPathology International, 1996
- Survival Trees by Goodness of SplitJournal of the American Statistical Association, 1993
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958